POLISENO, LAURA
 Distribuzione geografica
Continente #
AS - Asia 20
EU - Europa 2
Totale 22
Nazione #
SG - Singapore 8
CN - Cina 7
KR - Corea 5
IT - Italia 2
Totale 22
Città #
Singapore 7
Guangzhou 6
Seoul 5
Florence 1
Totale 19
Nome #
Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma 3
Biosafety and Biokinetics of Noble Metals: The Impact of Their Chemical Nature 3
Proteomics pipeline for phosphoenrichment and its application on a human melanoma cell model 2
null 2
p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells 1
Systematic evaluation of the microRNAome through miR-CATCHv2.0 identifies positive and negative regulators of BRAF-X1 mRNA 1
PARP1 negatively regulates MAPK signaling by impairing BRAF-X1 translation 1
PTENP1 is a ceRNA for PTEN: it's CRISPR clear 1
The landscape of BRAF transcript and protein variants in human cancer 1
Inducible modulation of miR-204 levels in a zebrafish melanoma model 1
Identification of BRAF 3'UTR Isoforms in Melanoma 1
Bcl2-low-expressing MCF7 cells undergo necrosis rather than apoptosis upon staurosporine treatment 1
Development of a yeast-based system to identify new hBRAFV600E functional interactors 1
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 1
Differential impact of BRAFV600E isoforms on tumorigenesis in a zebrafish model of melanoma 1
Alkaline Phosphatase-Positive Immortal Mouse Embryo Fibroblasts Are Cells in a Transitional Reprogramming State Induced to Face Environmental Stresses 1
Bcl2-negative MCF7 cells overexpress p53: Implications for the cell cycle and sensitivity to cytotoxic drugs 1
Totale 23
Categoria #
all - tutte 557
article - articoli 499
book - libri 19
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 39
Totale 1.114


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202415 0 0 0 0 0 0 0 0 1 0 12 2
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 23